Figure 2From: Development of skin hypopigmentation in a patient with metastatic papillary carcinoma thyroid treated with Sorafenib Photograph of same patient six weeks after discontinuation of sorafenib showing return of his normal skin colour with regaining of hairs over scalp, eye brows and moustache. Back to article page